Literature DB >> 14693233

Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy?

O Bettendorf1, J Piffkò, A Bànkfalvi.   

Abstract

An escalation in the incidence of oral cancer and its attributable mortality has been observed in recent decades in Europe; oral cancer is expected to become a public health problem in the foreseeable future. However, survival rates have remained at a disappointingly stable level despite significant development in the multimodality treatment of the disease. Additionally, due to the limited prognostic value of conventional prognostic factors and the uniformity of treatment strategies, several patients are still over- or under-treated with significant personal and socio-economical impact. Here we review some promising prognostic and predictive markers that can help the clinician to improve prognostic accuracy and define the most appropriate management for the individual patient with oral cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693233     DOI: 10.1016/j.oraloncology.2003.08.010

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  47 in total

1.  Expression of E-cadherin, Twist, and p53 and their prognostic value in patients with oral squamous cell carcinoma.

Authors:  Chi-Chen Fan; Tao-Yeuan Wang; Yen-An Cheng; Shih Sheng Jiang; Chien-Wen Cheng; Alan Yueh-Luen Lee; Ting-Yu Kao
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-30       Impact factor: 4.553

2.  High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.

Authors:  Matti Pukkila; Ari Kosunen; Kirsi Ropponen; Jukka Virtaniemi; Jari Kellokoski; Eero Kumpulainen; Risto Pirinen; Juhani Nuutinen; Risto Johansson; Veli-Matti Kosma
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

3.  PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients.

Authors:  Nisreen Sherif Alyasiri; Syed Jafar Mehdi; M Shabbir Alam; Asgar Ali; Ashish K Mandal; Sunita Gupta; Ishwar Singh; M Moshahid Alam Rizvi
Journal:  J Cancer Res Clin Oncol       Date:  2011-10-28       Impact factor: 4.553

4.  Notch1 mutations are drivers of oral tumorigenesis.

Authors:  Evgeny Izumchenko; Kai Sun; Sian Jones; Mariana Brait; Nishant Agrawal; Wayne Koch; Christine L McCord; David R Riley; Samuel V Angiuoli; Victor E Velculescu; Wei-Wen Jiang; David Sidransky
Journal:  Cancer Prev Res (Phila)       Date:  2014-11-18

5.  Tubulin α-6 chain is a stably expressed reference gene in archival samples of normal oral tissue and oral squamous cell carcinoma.

Authors:  Matilda Rentoft; Sara Hultin; Philip John Coates; Göran Laurell; Karin Nylander
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

6.  14-3-3ζ regulates immune response through Stat3 signaling in oral squamous cell carcinoma.

Authors:  Xinguang Han; Yongfu Han; Huifeng Jiao; Yaqiong Jie
Journal:  Mol Cells       Date:  2014-12-30       Impact factor: 5.034

7.  CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.

Authors:  Henning Hanken; Alexander Gröbe; Georg Cachovan; Ralf Smeets; Ronald Simon; Guido Sauter; Max Heiland; Marco Blessmann
Journal:  Clin Oral Investig       Date:  2013-03-15       Impact factor: 3.573

8.  Clinical significance of phosphatidyl inositol synthase overexpression in oral cancer.

Authors:  Jatinder Kaur; Meenakshi Sawhney; Siddartha Dattagupta; Nootan K Shukla; Anurag Srivastava; Ranju Ralhan
Journal:  BMC Cancer       Date:  2010-04-28       Impact factor: 4.430

9.  Neoadjuvant chemotherapy: does it have benefits for the surgeon in the treatment of advanced squamous cell cancer of the oral cavity?

Authors:  Lajos Olasz; József Szalma; Eniko Orsi; Tamás Tornóczky; Tamás Markó; Zoltán Nyárády
Journal:  Pathol Oncol Res       Date:  2009-09-12       Impact factor: 3.201

10.  Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.

Authors:  Ranju Ralhan; Leroi V Desouza; Ajay Matta; Satyendra Chandra Tripathi; Shaun Ghanny; Siddartha Datta Gupta; Sudhir Bahadur; K W Michael Siu
Journal:  Mol Cell Proteomics       Date:  2008-03-13       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.